Skip to content

Electroacupuncture to relieve diarrhea after chemotherapy: a randomized controlled trial

Electroacupuncture to relieve diarrhea after chemotherapy:a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003573
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-induced diarrhoea

Interventions

Electroacupuncture group:Electroacupuncture

Sponsors

Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The selected cases must meet the tumor diagnosis criteria of the "China Common Malignant Tumor Diagnosis and Treatment Standards" of the Health Commission of the People's Republic of China, and are confirmed to be malignant by histopathology and/or cytology; 2. Those who are prepared to receive or are receiving platinum, paclitaxel, or vincristine drugs as planned, and have diarrhea after chemotherapy; 3. Between 18-75 years old; 4. ECOG = 6 months; 5. No serious heart, liver, lung, or kidney organic disease; 6. Voluntary signing of informed consent to join the researcher.

Exclusion criteria

Exclusion criteria: 1. Patients with upper respiratory tract infection and other symptoms of infection at the time of consultation; 2. Those who have recently used antibiotics and other drugs that may cause diarrhea; 3. Women who are pregnant, breastfeeding, or planning to become pregnant during the trial period; 4. Patients with clinically significant ECG abnormalities; 5. People with pacemakers; 6. Participate in other clinical trials within 30 days; 7. Those with gastrointestinal tumors that may affect bowel function as judged by a specialist; 8. Those with functional bowel disease or intestinal infectious disease; 9. Colostomy; 10. People who use opioid analgesics; 11. People with severe intestinal obstruction and incomplete intestinal obstruction; 12. People with severe coagulopathy and bleeding tendency; 13. People with a tendency to severe gastrointestinal perforation; 14. People with mental illness; 15. Less than 4 weeks since the last chemotherapy; 16. Lactose intolerant; 17. Patients with celiac disease; 18. Patients with type 1 diabetes or uncontrolled type 2 diabetes.

Design outcomes

Primary

MeasureTime frame
WHOQOL;Days of diarrhea;Incidence of diarrhea;Fecal trait score;FACIT-D diarrhea subscale;

Secondary

MeasureTime frame
Acupuncture Expectation Value Evaluation;Overall effect evaluation;Evaluation of Acupuncture Blind Method;

Countries

China

Contacts

Public ContactYuhang Wang

Nanjing University of Chinese Medicine

njwyh1985@163.com+86 18752018817

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026